When Is Off-Label Drug Use in the Patient's Best Interest?

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.36 Ophthalmology; 1.36.1207 Behcet's Disease
Web Of Science research areas: Ophthalmology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Title: When Is Off-Label Drug Use in the Patient's Best Interest?
Creators: Philip J Rosenfeld - Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida
Kenneth W Goodman - Department of Medicine and Director of the Bioethics Program, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
Publication Details: American journal of ophthalmology, Vol.147(5), pp.761-763
Publisher: Elsevier Inc
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Medicine; UMMG Department of Ophthalmology
Language: English
Resource Type: Journal article
PMID: 19376327
Record Identifier: 991031599094602976